Inhalers used to treat symptoms of respiratory disease can be potent sources of greenhouse gases. Drugmakers are planning to ...

Chronic obstructive pulmonary disease is one of the world’s leading causes of death - more than 300 million live with the ...

The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce ...

Caroline Quill, MD, of the University of Rochester Medical Center, highlighted the potential of artificial intelligence (AI) ...

A poster presented at the CHEST 2024 annual meeting shows that inhaled treprostinil (iTRE) reduces hospitalizations in ...

Cruises are a great way for travelers with COPD to see the world. Most large cruise lines allow passengers to travel with ...

Early fall is when asthma flare-ups peak in the US, and a warming climate is bad news for sufferers: It means more ground-level ozone, a longer pollen season and more wildfire smoke — all ...

Patients with COPD and type 2 diabetes using SGLT2i were much less likely to have ER visits and hospitalizations related to COPD exacerbations.

Sure, having a cold or respiratory infection can temporarily make it harder to breathe. But if excessive coughing and ...

Learn how dupilumab significantly improves quality of life in COPD patients with type 2 inflammation, according to phase 3 ...